Definium Therapeutics, Inc. (DFTX) KPIs and segments

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30

$32.08−0.92 (-2.79%)

Close on Nov 13, 2026Market cap $4.31BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Definium Therapeutics's business

Coming soon

This tab will track the numbers specific to Definium Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?